Home » CF Foundation Therapeutics, Predix Announce Collaboration
CF Foundation Therapeutics, Predix Announce Collaboration
Predix Pharmaceuticals Holdings Inc., a drug discovery and development company, and Cystic Fibrosis Foundation Therapeutics (CFFT), the drug discovery and development affiliate of the Cystic Fibrosis Foundation, announced that they have signed a research, development and commercialization agreement. Predix will receive up to $12.5 million in milestone-driven funds over the next three years through a therapeutics development award from CFFT for two programs.
Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=894603&fid=942)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May